Lumentum CEO Defends $115B Marvell Deal as Offer Value Roughly Halves
Lumentum's CEO calls the all-stock Marvell merger 'even more powerful' as both stocks slide again. The fixed 4.5x ratio now implies about $592 a share, not $1,132.
Lumentum CEO Michael Hurlston says Marvell's $115 billion all-stock takeover is "even more powerful" after another selloff. Premarket on Nov. 20, Lumentum was down about 6% near $503 and Marvell about 5% near $131, according to Benzinga Pro. Because the exchange ratio is fixed, every Marvell drop cuts the deal's value for Lumentum holders, and a close is not expected until 2028.
What happened
Marvell announced on Nov. 2 that it will buy Lumentum at 4.5 Marvell shares per Lumentum share. The headline value was about $1,132 per Lumentum share, a 23.9% premium to the Oct. 28 close. The stocks fell on the announcement: Lumentum nearly 19% and Marvell about 13%, by one report.
Since then the slide has continued. Marvell and Lumentum are down 45% and 42% since the Oct. 28 close, per CNBC. Hurlston told CNBC's "Mad Money": "Our numbers are phenomenal, and we feel the combination is even more powerful." He also conceded, "We've got work to do with our shareholders."
My arithmetic: 4.5 × $131.48 is about $592 per share, roughly 48% below the $1,132 headline. Lumentum at about $503 sits roughly 15% below that implied value.
Why it matters
The deal is a bet that light, not copper, wins AI data-center connections. The currency for that bet is Marvell stock, and it is falling with the wider AI-chip rout. A gap between offer value and target price usually signals doubt about the stock currency, the closing timeline, or both.
Three risks stand out:
- Dilution: Marvell holders would own about 67% of the combined company, Lumentum holders about 33%, on a fully diluted basis.
- Regulation: The deal needs antitrust and other regulatory approvals, potentially including foreign ones. Marvell owes Lumentum a $3.2 billion fee if the deal fails over certain regulatory conditions. The outside date is Nov. 1, 2027, extendable to Aug. 1, 2028 if approvals are pending.
- Time: Closing is expected in the first half of 2028, so the exchange ratio will keep floating for well over a year.
For peers such as Coherent, the deal is a mixed signal. It values scarce optical components richly. But the same selloff that hits Marvell can also weigh on optical names, a reminder that market cycles pull the whole group. Optical stocks had already moved on the U.S. push against Chinese optical gear.
What to watch next
- Marvell's next earnings report, which Hurlston flagged as a chance to show investors the numbers.
- The merger S-4 filing and Lumentum's next results.
- Shareholder votes at both companies.
- Any sign of how regulators, including in China, will approach the review.
- The Lumentum-to-implied-value gap: widening means more doubt, narrowing means less.
Hurlston says the deal proceeds unless shareholders vote no or regulators refuse approval. Until then, Lumentum holders effectively carry exposure tied to Marvell's share price. Readers can see how volatility and drawdowns affect such positions.
Sources (6)
- Benzinga: Lumentum CEO Says Marvell Deal Is 'Even More Powerful' Despite Stock Selloff
- CNBC: Lumentum CEO defends Marvell deal after stock plunge
- CNBC: Marvell to buy Lumentum in all-stock deal
- Semafor: 'It's been a rough go': Lumentum's CEO on his $115 billion Marvell deal
- 24/7 Wall St.: Lumentum Is Down 33% in a Month as Marvell's Slide Shrinks Its Buyout Value
- Qz: Marvell agreed to acquire Lumentum in $115 billion stock deal
This analysis is for information only and is not investment advice. Prices and figures as of publication.